1-6 of 6
brentuximab vedotin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure

Clinical Trials & Observations
Philippe Armand, John Kuruvilla, Jean-Marie Michot, Vincent Ribrag, Pier Luigi Zinzani, Ying Zhu, Patricia Marinello, Akash Nahar, Craig H. Moskowitz
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2617–2622.
https://doi.org/10.1182/bloodadvances.2019001367
Published: 2020
Includes: Supplemental data
Journal Articles

Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT

Clinical Trials & Observations
Talha Badar, Narendranath Epperla, Aniko Szabo, Steven Borson, John Vaughn, Gemlyn George, Neeraj Saini, Abdul Rashid Shah, Romil D. Patel, Sairah Ahmed, Nirav N. Shah, Amanda F. Cashen, Mehdi Hamadani, Timothy S. Fenske
Journal: Blood Advances
Blood Adv (2020) 4 (1): 47–54.
https://doi.org/10.1182/bloodadvances.2019000736
Published: 2020
Journal Articles

A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis

Clinical Trials & Observations
Jason Gotlib, John H. Baird, Tracy I. George, Cheryl Langford, Isabel Reyes, Justin Abuel, Cecelia Perkins, Kurt Schroeder, Prithviraj Bose, Srdan Verstovsek
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2264–2271.
https://doi.org/10.1182/bloodadvances.2019000152
Published: 2019
Includes: Supplemental data
Journal Articles

Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma

Clinical Trials & Observations
M. Picardi, R. Della Pepa, C. Giordano, N. Pugliese, C. Mortaruolo, F. Trastulli, M. G. Rascato, I. Cappuccio, M. Raimondo, M. Memoli, M. Monteverde, M. Mascolo, F. Pane
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1546–1552.
https://doi.org/10.1182/bloodadvances.2019000123
Published: 2019
Journal Articles

Activity of brentuximab vedotin in AIDS-related primary effusion lymphoma

Clinical Trials & Observations
Victoria A. Chang, Huan-You Wang, Erin G. Reid
Journal: Blood Advances
Blood Adv (2019) 3 (5): 766–768.
https://doi.org/10.1182/bloodadvances.2018026351
Published: 2019
Journal Articles

Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma

Clinical Trials & Observations
Chia-Ching Wang, Cassandra Thanh, Erica A. Gibson, Maya Ball-Burack, Louise E. Hogan, Benjamin Descours, Norman Jones, Alexander B. Carvidi, Sadie Munter, Sonia Bakkour, Michael P. Busch, Jeffrey M. Milush, Steven G. Deeks, Timothy J. Henrich
Journal: Blood Advances
Blood Adv (2018) 2 (23): 3479–3482.
https://doi.org/10.1182/bloodadvances.2018024364
Published: 2018
Includes: Supplemental data